Correction to: Targeted therapy with anlotinib for a H3K27M-mutant diffuse midline glioma patient with PDGFR‑α mutation: a case report

Detalles Bibliográficos
Autores principales: Wang, Qiang, Niu, Wenhao, Pan, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486137/
https://www.ncbi.nlm.nih.gov/pubmed/35278141
http://dx.doi.org/10.1007/s00701-022-05181-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486137/
https://www.ncbi.nlm.nih.gov/pubmed/35278141
http://dx.doi.org/10.1007/s00701-022-05181-2

Ejemplares similares